Author:
Singh Ravinder Pal,Gupta Nishkarsh,Kaur Tanudeep,Gupta Anju
Abstract
Primary gastrointestinal mucormycosis is a rare disease associated with an increased mortality and is rarely reported in an immunocompetent host. We report the first case of mucormycosis-associated colonic perforation in a COVID-19 patient with a favourable outcome. A 48-year-old healthy male doctor in home isolation due to COVID-19 was admitted to COVID-19 intensive care unit when his symptoms deteriorated. The patient was put on non-invasive ventilation (NIV) using Bilevel Positive Airway Pressure (BiPAP) and treatment given as per existing hospital protocol. The patient improved clinically, and was discharged on day 10 of admission. Two days later, he presented with acute gastrointestinal symptoms to the emergency department. A diagnosis of perforation peritonitis was made, the patient was stabilised and sigmoid colectomy with descending colon colostomy was done. A diagnosis of gastrointestinal mucormycosis was made and injectable antifungal was started. The patient was discharged after his general conditions improved.
Reference15 articles.
1. Clinical management protocol for COVID-19, 2020. Available: https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf [Accessed : July 7, 2020].
2. Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
3. Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
4. Epidemiology and clinical manifestations of mucormycosis;Petrikkos;Clin Infect Dis,2012
5. Gastrointestinal mucormycosis: an evolving disease;Spellberg;Gastroenterol Hepatol,2012
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献